OxRML/AgentSLR huggingface dataset:
Parameter: Reproduction number (Effective, Re) (Reproduction number)
Value: 0.16 No units ()
Exponent (base 10): 0
Uncertainty: 0.13 - 0.19 (95% CI)
Statistical approach: Estimated model parameter
Reproduction number method: Branching process Vector-human
Trimester exposed: Unspecified
Population: General population, sex: Unspecified, ages  to 
Country: United States
Location: Florida
Setting: Population based, Unspecified
Study period: 1 May 2016 - 23 Sep 2016
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 17 Percentage (%) (Unspecified)
Exponent (base 10): 0
Numerator/denominator: 17 / 92 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Bangladesh
Setting: Population based, Unspecified
Sample size: 92
Study period: 2014
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 28 Percentage (%) (Unspecified)
Exponent (base 10): 0
Numerator/denominator: 15 / 52 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Bangladesh
Setting: Population based, Unspecified
Sample size: 52
Study period: 2015
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 3.1 Percentage (%) (Unspecified)
Exponent (base 10): 0
Bounds: 0 - 11.5
Numerator/denominator: 12 / 16 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Disaggregated by: Time
Population: General population, sex: Both, ages 16 to 
Country: Bangladesh
Setting: Population based, Unspecified
Sample size: 418
Study period: 2011 - 2015
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 4.3 Percentage (%) (Unspecified)
Exponent (base 10): 0
Bounds: 0 - 13.2
Numerator/denominator: 5 / 15 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Disaggregated by: Time
Population: Persons under investigation, sex: Both, ages  to 
Country: Bangladesh
Setting: Population based, Unspecified
Sample size: 418
Study period: 2011 - 2015
Parameter: Seroprevalence - IgM (Seroprevalence)
Value:  Percentage (%) (Unspecified)
Exponent (base 10): 0
Numerator/denominator: 3 / 418 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages 16 to 
Country: Bangladesh
Setting: Population based, Unspecified
Sample size: 418
Study period: 2011 - 2015
Parameter: Seroprevalence - IgM (Seroprevalence)
Value:  Percentage (%) (Unspecified)
Exponent (base 10): 0
Numerator/denominator: 1 / 418 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: Persons under investigation, sex: Both, ages  to 
Country: Bangladesh
Setting: Population based, Unspecified
Sample size: 418
Study period: 2011 - 2015
Parameter: Seroprevalence - HAI/HI (Seroprevalence)
Value: 3.3 Percentage (%) (Mean)
Exponent (base 10): 0
Bounds: 0 - 20
Numerator/denominator: 27 / 822 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Disaggregated by: Age, Other
Population: General population, sex: , ages  to 
Country: Kenya
Location: Central Nyanza
Setting: Population based, Unspecified
Sample size: 822
Study period: Nov 1966 - Apr 1968
Parameter: Seroprevalence - HAI/HI (Seroprevalence)
Value: 1.3 Percentage (%) (Mean)
Exponent (base 10): 0
Bounds: 0 - 7.7
Numerator/denominator: 14 / 1042 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Disaggregated by: Age, Other
Population: General population, sex: , ages  to 
Country: Kenya
Location: Kitui District
Setting: Population based, Unspecified
Sample size: 1042
Study period: Nov 1966 - Apr 1968
Parameter: Seroprevalence - HAI/HI (Seroprevalence)
Value: 52 Percentage (%) (Mean)
Exponent (base 10): 0
Bounds: 7.2 - 89.6
Numerator/denominator: 434 / 834 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Disaggregated by: Age, Other
Population: General population, sex: , ages  to 
Country: Kenya
Location: Malindi District
Setting: Population based, Unspecified
Sample size: 834
Study period: Nov 1966 - Apr 1968
Parameter: Mutations - evolutionary rate (Mutations)
Value: 9.2 Substitutions/site/year (Mean)
Exponent (base 10): -4
Uncertainty: 7.1 - 12 (95% CrI)
Statistical approach: Estimated model parameter
Genome site: Whole genome sequence
Country: Multi-country: Americas, Asia, Oceania
Sample size: 65
Study period: 1966 - Aug 2017
Parameter: Severity - case fatality rate (CFR) (Severity)
Value: 8.3 Percentage (%) (Unspecified)
Exponent (base 10): 0
Uncertainty: 7.2 - 9.6 (95% CI)
Bounds: 3.4 - 19
Case definition: Confirmed
Numerator/denominator: 171 / 2063 (method: Naive)
Statistical approach: Observed sample statistic
Population: Other, sex: Both, ages  to 
Country: Brazil
Setting: Hospital based, 
Sample size: 2063
Study period: 10 Nov 2015 - 15 Oct 2016
Parameter: Severity - case fatality rate (CFR) (Severity)
Value: 10.5 Percentage (%) (Unspecified)
Exponent (base 10): 0
Uncertainty: 9.5 - 11.7 (95% CI)
Bounds: 3.4 - 19
Case definition: Confirmed;Probable
Numerator/denominator: 313 / 2974 (method: Unspecified)
Statistical approach: Estimated model parameter
Population: Other, sex: Both, ages  to 
Country: Brazil
Setting: Hospital based, 
Sample size: 2974
Study period: 10 Nov 2015 - 15 Oct 2016
Parameter: Seroprevalence - IgM (Seroprevalence)
Value: 7 Percentage (%) (Central)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 22 / 295 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Both, ages 0 to 0
Country: United States
Location: New York
Setting: Hospital based, Urban area
Sample size: 295
Study period: 1 Jan 2016 - 30 Jun 2017
Parameter: Reproduction number (Effective; Re) - Sexual (Reproduction number)
Value:  No units (Unspecified)
Exponent (base 10): 0
Bounds: 1.6 - 10.3
Statistical approach: Estimated model parameter
Disaggregated by: Method, Time
Reproduction number method: Other Unspecified
Population: General population, sex: Unspecified, ages  to 
Country: Colombia
Location: Antioquia
Setting: Population based, 
Study period: 14 Oct 2015 - 10 Apr 2016
Parameter: Human delay - infectious period (Human delay)
Value: 5.2 Days (Median)
Exponent (base 10): 0
Uncertainty: 4.1 - 6.7 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method:  Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Tahiti, French Polynesia
Setting: Population based, 
Study period: Oct 2013 - Apr 2014
Parameter: Human delay - infectious period (Human delay)
Value: 5.5 Days (Median)
Exponent (base 10): 0
Uncertainty: 4.2 - 6.8 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method:  Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: New Caledonia
Setting: Population based, 
Study period: 12 Nov 2013 - Aug 2014
Parameter: Human delay - infectious period (Human delay)
Value: 5.3 Days (Median)
Exponent (base 10): 0
Uncertainty: 4.1 - 6.6 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method:  Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Federated States of Micronesia
Location: Yap Island
Setting: Population based, 
Study period: 1 Apr 2007 - 29 Jul 2007
Parameter: Human delay - infectious period (Human delay)
Value: 5.3 Days (Median)
Exponent (base 10): 0
Uncertainty: 4.1 - 6.7 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method:  Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Mo'orea, French Polynesia
Setting: Population based, 
Study period: Oct 2013 - Apr 2014
Parameter: Human delay - infectious period (Human delay)
Value: 5.4 Days (Median)
Exponent (base 10): 0
Uncertainty: 4.1 - 6.8 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method:  Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: New Caledonia
Setting: Population based, 
Study period: 12 Nov 2013 - Aug 2014
Parameter: Mosquito delay - extrinsic incubation period (Mosquito)
Value: 10.6 Days (Median)
Exponent (base 10): 0
Uncertainty: 8.7 - 12.5 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method:  Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Federated States of Micronesia
Location: Yap Island
Setting: Population based, 
Study period: 1 Apr 2007 - 29 Jul 2007
Parameter: Mosquito delay - extrinsic incubation period (Mosquito)
Value: 10.5 Days (Median)
Exponent (base 10): 0
Uncertainty: 8.6 - 12.4 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method:  Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Mo'orea, French Polynesia
Setting: Population based, 
Study period: Oct 2013 - Apr 2014
Parameter: Mosquito delay - extrinsic incubation period (Mosquito)
Value: 10.5 Days (Median)
Exponent (base 10): 0
Uncertainty: 8.6 - 12.6 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method:  Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Tahiti, French Polynesia
Setting: Population based, 
Study period: Oct 2013 - Apr 2014
Parameter: Mosquito delay - extrinsic incubation period (Mosquito)
Value: 10.7 Days (Median)
Exponent (base 10): 0
Uncertainty: 8.9 - 12.5 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method:  Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: New Caledonia
Setting: Population based, 
Study period: 12 Nov 2013 - Aug 2014
Parameter: Mosquito delay - extrinsic incubation period (Mosquito)
Value: 10.7 Days (Median)
Exponent (base 10): 0
Uncertainty: 8.8 - 12.7 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method:  Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Federated States of Micronesia
Location: Yap Island
Setting: Population based, 
Study period: 1 Apr 2007 - 29 Jul 2007
Parameter: Mosquito delay - extrinsic incubation period (Mosquito)
Value: 10.6 Days (Median)
Exponent (base 10): 0
Uncertainty: 8.6 - 12.6 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method:  Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Mo'orea, French Polynesia
Setting: Population based, 
Study period: Oct 2013 - Apr 2014
Parameter: Mosquito delay - extrinsic incubation period (Mosquito)
Value: 10.5 Days (Median)
Exponent (base 10): 0
Uncertainty: 8.5 - 12.5 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method:  Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Tahiti, French Polynesia
Setting: Population based, 
Study period: Oct 2013 - Apr 2014
Parameter: Mosquito delay - extrinsic incubation period (Mosquito)
Value: 10.8 Days (Median)
Exponent (base 10): 0
Uncertainty: 8.9 - 12.8 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method:  Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: New Caledonia
Setting: Population based, 
Study period: 12 Nov 2013 - Aug 2014
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.6 No units (Median)
Exponent (base 10): 0
Uncertainty: 2.2 - 3.3 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Next generation matrix Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Mo'orea, French Polynesia
Setting: Population based, 
Study period: Oct 2013 - Apr 2014
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.4 No units (Median)
Exponent (base 10): 0
Uncertainty: 2 - 3.2 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Next generation matrix Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Tahiti, French Polynesia
Setting: Population based, 
Study period: Oct 2013 - Apr 2014
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2 No units (Median)
Exponent (base 10): 0
Uncertainty: 1.8 - 2.2 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Next generation matrix Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: New Caledonia
Setting: Population based, 
Study period: 12 Nov 2013 - Aug 2014
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.2 No units (Median)
Exponent (base 10): 0
Uncertainty: 1.9 - 2.6 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Next generation matrix Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Federated States of Micronesia
Location: Yap Island
Setting: Population based, 
Study period: 1 Apr 2007 - 29 Jul 2007
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 3.2 No units (Median)
Exponent (base 10): 0
Uncertainty: 2.4 - 4.1 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Next generation matrix Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Federated States of Micronesia
Location: Yap Island
Setting: Population based, 
Study period: 1 Apr 2007 - 29 Jul 2007
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 1.8 No units (Median)
Exponent (base 10): 0
Uncertainty: 1.6 - 2 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Next generation matrix Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Mo'orea, French Polynesia
Setting: Population based, 
Study period: Oct 2013 - Apr 2014
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 1.6 No units (Median)
Exponent (base 10): 0
Uncertainty: 1.5 - 1.7 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Next generation matrix Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Tahiti, French Polynesia
Setting: Population based, 
Study period: Oct 2013 - Apr 2014
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 1.6 No units (Median)
Exponent (base 10): 0
Uncertainty: 1.5 - 1.7 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Next generation matrix Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: New Caledonia
Setting: Population based, 
Study period: 12 Nov 2013 - Aug 2014
Parameter: Human delay - infectious period (Human delay)
Value: 5.2 Days (Median)
Exponent (base 10): 0
Uncertainty: 4.1 - 6.7 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method:  Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Federated States of Micronesia
Location: Yap Island
Setting: Population based, 
Study period: 1 Apr 2007 - 29 Jul 2007
Parameter: Human delay - infectious period (Human delay)
Value: 5.2 Days (Median)
Exponent (base 10): 0
Uncertainty: 4.1 - 6.8 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method:  Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Mo'orea, French Polynesia
Setting: Population based, 
Study period: Oct 2013 - Apr 2014
Parameter: Seroprevalence - IgM (Seroprevalence)
Value: 17 Percentage (%) (Central)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 17 / 98 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages  to 
Country: France
Location: Papeete, Tahiti, French Polynesia
Setting: Hospital based, Unspecified
Sample size: 98
Study period: Nov 2013 - Feb 2014
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 26 Percentage (%) (Central)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 25 / 98 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages  to 
Country: France
Location: Papeete, Tahiti, French Polynesia
Setting: Hospital based, Unspecified
Sample size: 98
Study period: Nov 2013 - Feb 2014
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 56 Percentage (%) (Central)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 54 / 98 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages  to 
Country: France
Location: Papeete, Tahiti, French Polynesia
Setting: Hospital based, Unspecified
Sample size: 98
Study period: Nov 2013 - Feb 2014
Parameter: Human delay - Onset to Negative PCR test in serum/plasma (Human delay)
Value: 2.56 Days (Mean)
Exponent (base 10): 0
Uncertainty: 1.53 (Standard Deviation)
Uncertainty (single): 1.53 (Standard Deviation)
Statistical approach: Observed sample statistic
Population: Household contacts of survivors, sex: Both, ages  to 
Country: Nicaragua
Location: Managua
Setting: Household based, Unspecified
Sample size: 25
Study period: 31 Aug 2016 - 21 Oct 2016
Parameter: Human delay - Onset to Negative PCR test in saliva (Human delay)
Value: 3.1 Days (Mean)
Exponent (base 10): 0
Uncertainty: 1.5 (Standard Deviation)
Uncertainty (single): 1.5 (Standard Deviation)
Statistical approach: Observed sample statistic
Population: Household contacts of survivors, sex: Both, ages  to 
Country: Nicaragua
Location: Managua
Setting: Household based, Unspecified
Sample size: 51
Study period: 31 Aug 2016 - 21 Oct 2016
Parameter: Human delay - Onset to Negative PCR test in urine (Human delay)
Value: 5.94 Days (Mean)
Exponent (base 10): 0
Uncertainty: 3.8 (Standard Deviation)
Uncertainty (single): 3.8 (Standard Deviation)
Statistical approach: Observed sample statistic
Population: Household contacts of survivors, sex: Both, ages  to 
Country: Nicaragua
Location: Managua
Setting: Household based, Unspecified
Sample size: 86
Study period: 31 Aug 2016 - 21 Oct 2016
Parameter: Seroprevalence - IgM (Seroprevalence)
Value:  No units ()
Exponent (base 10): 0
Numerator/denominator: 23 / 142 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Disaggregated by: Age, Sex, Symptoms
Population: Household contacts of survivors, sex: Both, ages  to 
Country: Nicaragua
Location: Managua
Setting: Household based, Unspecified
Sample size: 142
Study period: 31 Aug 2016 - 21 Oct 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 1.8 No units (Central)
Exponent (base 10): 0
Uncertainty: 1.78 - 1.82 (95% CI)
Statistical approach: Observed sample statistic
Reproduction number method: Growth rate Unspecified
Population: General population, sex: Both, ages  to 
Country: Dominican Republic
Setting: Population based, Both urban and rural areas
Sample size: 5235
Study period: Jan 2016 - Dec 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 1.84 No units (Central)
Exponent (base 10): 0
Uncertainty: 1.82 - 1.87 (95% CI)
Statistical approach: Observed sample statistic
Disaggregated by: Age
Reproduction number method: Growth rate Unspecified
Population: General population, sex: Female, ages  to 
Country: Dominican Republic
Setting: Population based, Both urban and rural areas
Study period: Jan 2016 - Dec 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 1.72 No units (Central)
Exponent (base 10): 0
Uncertainty: 1.69 - 1.75 (95% CI)
Statistical approach: Observed sample statistic
Disaggregated by: Age
Reproduction number method: Growth rate Unspecified
Population: General population, sex: Male, ages  to 
Country: Dominican Republic
Setting: Population based, Both urban and rural areas
Study period: Jan 2016 - Dec 2016
Parameter: Attack rate (Attack rate)
Value: 0.05 Percentage (%) (Mean)
Exponent (base 10): 0
Uncertainty: 0.01 - 0.29 (95% CI)
Statistical approach: Observed sample statistic
Population: Blood donors, sex: Both, ages  to 
Country: Brazil
Location: Campinas
Setting: Population based, Urban area
Sample size: 1962
Study period: Mar 2015
Parameter: Attack rate (Attack rate)
Value: 0.17 Percentage (%) (Mean)
Exponent (base 10): 0
Uncertainty: 0.06 - 0.5 (95% CI)
Statistical approach: Observed sample statistic
Population: Blood donors, sex: Both, ages  to 
Country: Brazil
Location: Campinas
Setting: Population based, Urban area
Sample size: 1775
Study period: Mar 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.53 No units (Mean)
Exponent (base 10): 0
Uncertainty: 1.59 - 3.45 (95% CI)
Statistical approach: Estimated model parameter
Reproduction number method: Compartmental model Human-human
Population: General population, sex: Both, ages  to 
Country: Brazil
Location: Rio de Janeiro
Setting: Population based, Urban area
Study period: 2015 - 2016
Parameter: Human delay - infectious period (Human delay)
Value: 9.599 Days (Mean)
Exponent (base 10): 0
Uncertainty: 7.673 - 11.701 (95% CI)
Statistical approach: Estimated model parameter
Disaggregated by: Sex
Population: General population, sex: Both, ages  to 
Country: Brazil
Location: Rio de Janeiro
Setting: Population based, Urban area
Study period: 2015 - 2016
Parameter: Human delay - infectious period (Human delay)
Value: 11.568 Days (Mean)
Exponent (base 10): 0
Uncertainty: 9.246 - 13.963 (HPDI 95%)
Statistical approach: Estimated model parameter
Population: General population, sex: Male, ages  to 
Country: Brazil
Location: Rio de Janeiro
Setting: Population based, Urban area
Study period: 2015 - 2016
Parameter: Human delay - infectious period (Human delay)
Value: 9.207 Days (Mean)
Exponent (base 10): 0
Uncertainty: 7.283 - 11.134 (HPDI 95%)
Statistical approach: Estimated model parameter
Population: General population, sex: Female, ages  to 
Country: Brazil
Location: Rio de Janeiro
Setting: Population based, Urban area
Study period: 2015 - 2016
Parameter: Human delay - infectious period (Human delay)
Value: 9.073 Days (Mean)
Exponent (base 10): 0
Uncertainty: 5.956 - 12.232 (HPDI 95%)
Statistical approach: Estimated model parameter
Population: Other, sex: Female, ages 14 to 48
Country: Brazil
Location: Rio de Janeiro
Setting: Population based, Urban area
Study period: 2015 - 2016
Parameter: Human delay - Onset to ZIKV RNA clearance from plasma (Human delay)
Value: 11.5 Days (Median)
Exponent (base 10): 0
Uncertainty: 6 - 64 (IQR)
Statistical approach: Estimated model parameter
Population: Persons under investigation, sex: Both, ages 18 to 63
Country: Italy
Location: Padova and Pavia, travel-related
Setting: Hospital based, Unspecified
Sample size: 30
Study period: Jan 2016 - Jan 2017
Parameter: Human delay - Onset to ZIKV RNA clearance from urine (Human delay)
Value: 24 Days (Median)
Exponent (base 10): 0
Uncertainty: 17 - 34 (IQR)
Statistical approach: Estimated model parameter
Population: Persons under investigation, sex: Both, ages 18 to 63
Country: Italy
Location: Padova and Pavia, travel-related
Setting: Hospital based, Unspecified
Sample size: 29
Study period: Jan 2016 - Jan 2017